Skip to content
Front page / What’s new

What's New

Here you will find information about cancer care and research, news, articles, patient stories and other materials about our work and services. Our Communications serves media and journalists and please contact our Communications via, viestinta@docrates.com.
Tiedotteet | 03.09.2024
Company information

Customer message 3. September, 2024

With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...

Read more
Tiedotteet | 27.08.2024
Company information

The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center

On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....

Read more
Tiedotteet | 06.08.2024
Colorectal cancer

New pharmacotherapy available for metastatic colorectal cancer

Docrates treats metastatic colorectal cancer in a personalised way, and its treatment recommendations are based on the latest research and...

Read more